Mediguide Ltd. – Trademark Portfolio

Entity Type: 16

Mediguide Ltd. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 9 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include GMPS, MEDIGUIDE, and MEDIGUIDE ENABLED. The owner is based in Haifa.

P.O. Box 15003

Matam Advanced Technology Center

Haifa 31053 , IL

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Mediguide Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (9 filings)

Surgical, medical, dental and veterinary apparatus and instruments

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Mediguide Ltd. have?

Mediguide Ltd. has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 abandoned, 3 cancelled.

What trademark classes does Mediguide Ltd. file in?

Mediguide Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Mediguide Ltd.'s most well-known trademarks?

Mediguide Ltd.'s registered trademark portfolio includes well-known marks such as GMPS, MEDIGUIDE, and MEDIGUIDE ENABLED. These are among 4 currently registered trademarks in the portfolio.

What is Mediguide Ltd.'s trademark registration success rate?

Mediguide Ltd. has a 40% trademark registration rate, with 4 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.